Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025
- Company to present at session titled “Personalizing Sepsis Treatment”
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its sponsorship of the Unite for Sepsis Symposium, taking place September 8 – 9, 2025, in Chicago, Illinois. The Company also announced that Debra Foster, Clinical Consultant at Spectral Medical, will participate in a featured session during the event.
Ms. Foster will contribute to the session titled “Personalizing Sepsis Treatment”, scheduled for Day 1 at 4:15 PM CT, which will highlight how individualized approaches may support earlier intervention and improved outcomes in sepsis care.
The Unite for Sepsis Symposium is a unique, in-person event convening an extraordinary community of clinicians, researchers, regulators, investors, innovators, and advocates. More than a symposium, Unite for Sepsis is a collaborative movement dedicated to transforming the way sepsis is prevented, diagnosed, and treated.
For more information or to register, please visit UniteforSepsis.org
finance.yahoo.com |
